Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration

PURPOSE: Although intraocular anti-vascular endothelial growth factors (anti-VEGFs) are effective as treatment of neovascular age-related macular degeneration (nAMD), the (economic) burden on the healthcare system is considerable. A treat-and-extend (T&E) regimen is associated with a lower numbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Quist, S. W., de Jong, L. A., van Asten, F., Knoester, P., Postma, M. J., Freriks, R. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511619/
https://www.ncbi.nlm.nih.gov/pubmed/34643793
http://dx.doi.org/10.1007/s00417-021-05359-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511619/
https://www.ncbi.nlm.nih.gov/pubmed/34643793
http://dx.doi.org/10.1007/s00417-021-05359-x

Ejemplares similares